Pharma-Bio Serv, Inc. (PBSV)
| Market Cap | 10.09M |
| Revenue (ttm) | 9.60M |
| Net Income (ttm) | -498.36K |
| Shares Out | 22.93M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | 4.00 |
| Dividend | 0.08 (17.05%) |
| Ex-Dividend Date | Feb 28, 2025 |
| Volume | 500 |
| Average Volume | 1,954 |
| Open | 0.4998 |
| Previous Close | 0.4400 |
| Day's Range | 0.4400 - 0.4998 |
| 52-Week Range | 0.3100 - 0.7500 |
| Beta | 0.64 |
| RSI | 36.87 |
| Earnings Date | Jun 13, 2025 |
About Pharma-Bio Serv
Pharma-Bio Serv, Inc. operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services, including regulatory compliance, validation, technology transfer, engineering, project management, and process support services. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 199... [Read more]
Financial Performance
Financial StatementsNews
Pharma-Bio Serv reports revenue of $2.5 million for quarter ended January 31, 2025
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025
DORADO, PUERTO RICO / ACCESS Newswire / March 17, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consu...
Pharma-Bio Serv reports FY results
Pharma-Bio Serv declares $0.075 dividend
Pharma-Bio Serv Announces Full Year Results
DORADO, PUERTO RICO / ACCESS Newswire / January 29, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and te...
Pharma-Bio Serv Announces Special Dividend
DORADO, PUERTO RICO / ACCESS Newswire / January 29, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and te...
Pharma-Bio Serv reports Q3 results
Pharma-Bio Serv (PBSV) reports Q3 revenue of $2.4M with a net income of $0.5M but a net loss of $0.3M for the quarter ended July 31, 2024.
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024
DORADO, PUERTO RICO / ACCESSWIRE / September 16, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consul...
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting ...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
DORADO, PUERTO RICO / ACCESSWIRE / March 18, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting...
Pharma-Bio Serv Announces Full Year Results
DORADO, PUERTO RICO / ACCESSWIRE / January 29, 2024 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technol...
Pharma-Bio Serv Announces Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / December 21, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consult...
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consul...
Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting ...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting...
Pharma-Bio Serv Retains Investment Banking Firm ACP Capital to Provide Investment Banking and M&A Advisory Services
DORADO, PUERTO RICO / ACCESSWIRE / February 7, 2023 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer supp...
Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2022
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consul...
Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2022
DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting ...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2022
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting...
Pharma-Bio Serv Announces Full Year Results and Declares a Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / February 11, 2022 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer sup...
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2021
DORADO, PUERTO RICO / ACCESSWIRE / September 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory, compliance, project management and technology transfer su...
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2021
Announces Regulatory and Compliance Advisory Board DORADO, PUERTO RICO / ACCESSWIRE / June 14, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project man...
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2021
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting...
Pharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special Dividend
DORADO, PUERTO RICO / ACCESSWIRE / January 5, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consultin...
Pharma-Bio Serv: High Quality Nanocap For A Low Price
Pharma-Bio Serv is a cheap stock based on EV/EBIT with good earnings quality based on various multi-year metrics.